Get the Stockscreener App
0.2754
10.76%
-0.0417
Sunshine Biopharma Inc stock is traded at $0.2754, with a volume of 2.38M.
It is down -10.76% in the last 24 hours and down -70.73% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$0.317
Open:
$0.301
24h Volume:
2.38M
Relative Volume:
0.19
Market Cap:
$4.46M
Revenue:
$36.31M
Net Income/Loss:
$-5.98M
P/E Ratio:
-0.1854
EPS:
-1.4848
Net Cash Flow:
$-6.17M
1W Performance:
-41.22%
1M Performance:
-70.73%
6M Performance:
-80.48%
1Y Performance:
-80.35%
1-Day Range:
$0.271
$0.3042
1-Week Range:
$0.28
$0.4552
52-Week Range:
$0.28
$2.43
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
0.2757 | 5.12M | 36.31M | -5.98M | -6.17M | -1.4848 |
TAK
Takeda Pharmaceutical Co Adr
|
16.04 | 51.03B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.91 | 40.20B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.16 | 40.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
77.95 | 32.81B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
558.57 | 23.86B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma receives patent for coronavirus treatment compounds - Investing.com
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology - standard-journal.com
New coronavirus patent aims to keep treatments working as virus mutates - Stock Titan
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today - Benzinga
Sunshine Biopharma (SBFM) Implements Reverse Stock Split for Nas - GuruFocus
Sunshine Biopharma stock tumbles after reverse split announcement By Investing.com - Investing.com Nigeria
Sunshine Biopharma stock tumbles after reverse split announcement - Investing.com
Sunshine Biopharma down after announcing 1-for-10 reverse stock split - MSN
Sunshine Biopharma announces 1-for-10 reverse stock split - Investing.com
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing - Weatherford Democrat
Sunshine Biopharma to cut shares from 21M to 2.1M via June 1 reverse split - Stock Titan
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW! - FinancialContent
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch - FinancialContent
Why is Sunshine Biopharma stock falling Tuesday? - MSN
Sunshine Biopharma stock rallies on Canadian approval for generic amoxicillin - MSN
Sunshine Biopharma Warrants (SBFMW) Surge 18% as Biotech Sector Shows Renewed InterestCrowd Verified Signals - Newser
L1 Capital holds 5.83% of Sunshine Biopharma (NASDAQ: SBFM) - Stock Titan
Sunshine Biopharma (SBFM) Slides 11.6% as Support at $0.44 Comes into FocusExpert Trade Signals - Newser
Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin - Sahm
What's going on in today's after hours session - ChartMill
Sunshine Biopharma (SBFM) reporting group held 805,000 shares, then sold stake - Stock Titan
Sunshine Biopharma (SBFM) Surges 15.6% on $6 Million Offering Close - Meyka
Most active stocks in Thursday's session - ChartMill
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Sunshine Biopharma Receives Canadian Approval For Generic Amoxicillin; Stock Up - RTTNews
What's going on in today's pre-market session - ChartMill
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin - Eagle-Tribune
Canada clears generic Amoxicillin, widening treatment choices - Stock Titan
$Sunshine Biopharma (SBFM.US)$ so much buy in but price not move up. - Moomoo
Sunshine Biopharma Raises $6 Million in Public Offering to Fund Operations and Drug Development - citybuzz -
Sunshine Biopharma Completes $6 Million Unit Offering - TipRanks
Sunshine Biopharma (NASDAQ: SBFM) closes $6M unit deal with $12M warrant upside - Stock Titan
Sunshine Biopharma closes $6 million public offering By Investing.com - Investing.com Nigeria
In today's session, these stocks are experiencing unusual volume. - ChartMill
Sunshine Biopharma closes $6 million public offering - Investing.com India
3 Penny Stocks to Watch Now, 5/19/26 - TipRanks
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering - ACCESS Newswire
Sunshine Biopharma raises $6M selling 12M units at $0.50 - Stock Titan
Sunshine Biopharma (NASDAQ: SBFM) sells 11.16M units, $6.0M raise with warrants - Stock Titan
$Sunshine Biopharma (SBFM.US)$ always take profits don’t matter if it 10% or higher - Moomoo
Sunshine Biopharma Surges 79.5% on $6 Million Public Offering - Meyka
Why Is Sunshine Biopharma Stock Falling Tuesday? - Benzinga
[EFFECT] Sunshine Biopharma Inc. SEC Filing - Stock Titan
Nasdaq Down 200 Points; Brady Earnings Top Views - Sahm
$Sunshine Biopharma (SBFM.US)$ not sure today…. - Moomoo
$Sunshine Biopharma (SBFM.US)$ something better than nothing ✅ - Moomoo
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
$Sunshine Biopharma (SBFM.US)$ still holding half for moon shot - Moomoo
$Sunshine Biopharma (SBFM.US)$ - Moomoo
Sunshine Biopharma Company Profile & Introduction - Moomoo
Sunshine Biopharma Stock Whipsaws After $6 Million Deal: Why the 50-Cent Price Matters - TechStock²
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):